InvestorsCustomer ServiceContact usNewsEventsMedia Highlights

Taking Innovation to Heart

CryoCath is a medical technology company that leads the world in creating catheter- and probe-based CryoTherapy products to treat cardiovascular disease. Traditionally, the use of freezing temperatures to treat diseased tissue has been limited by the inability to deliver the treatment in a minimally invasive manner. We have successfully overcome this obstacle by developing flexible, steerable, minimally invasive catheters to deliver cold therapy safely and effectively.

Our CryoTherapy Revolution

CryoCath has blazed a trail in CryoTherapy and continues to do so with the successful U.S. launch of Freezor®, a cryocatheter for the treatment of AVNRT. To get a better idea of where we've come from and where we're going, take a look at other important company milestones.

A Culture of Leadership, Integrity and Respect

We believe that the only way for us to maintain our leadership is through empowerment, inspiration, teamwork and conviction. And as important as our R&D and commercial successes are, we are also driven by our ability to improve peoples lives profoundly through our clinical innovations.

In a very short time span, we've succeeded in building a world-class company that excels across the whole organization – from R&D and manufacturing to marketing and customer service.